Date published: 2025-12-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

CINP Inhibitors

The chemical class designated as CINP Inhibitors encompasses a variety of compounds recognized for their capacity to influence the activity of Cyclin-Dependent Kinase 2 Interacting Protein (CINP). This group is characterized not by a uniform chemical structure but by their functional potential to modulate the biological activities associated with CINP. Key to the development of these inhibitors is an understanding of CINP's role in cell cycle regulation and its interaction with Cyclin-Dependent Kinase 2 (CDK2), a critical enzyme in controlling cell cycle progression. The inhibitors aim to modulate this interaction or impact the pathways in which CINP is involved, thereby influencing cell cycle dynamics and other related cellular processes.

The mechanisms of action for CINP inhibitors are diverse, reflecting the complexity of CINP's biological functions. One primary approach is to target the interaction between CINP and CDK2. By disrupting this specific protein-protein interaction, these inhibitors can alter the functional dynamics of CINP, impacting its role in cell cycle regulation. This disruption is significant as it can affect the progression of the cell cycle, particularly the transition from the G1 phase to the S phase, a critical phase where DNA replication occurs. Another approach involves modulating the kinase activity of CDK2, thereby indirectly affecting CINP's role. Since CINP's function is closely tied to the activity of CDK2, compounds that influence CDK2 can also have implications for CINP's regulatory role. Additionally, the inhibitors may encompass compounds that affect signaling pathways and cellular processes associated with the function of CINP, such as DNA damage response and genomic stability maintenance.In summaryr, the class of CINP Inhibitors is marked by a broad spectrum of compounds, each with unique characteristics but united by their potential to influence the activity of CINP. The exploration and development of these inhibitors are driven by detailed research into the molecular biology of CINP and its interaction with CDK2. Understanding these interactions at a molecular level is crucial for developing strategies to modulate CINP's activity, which has implications for understanding cell cycle regulation in greater detail. This research area continues to evolve, contributing to our broader understanding of cellular regulation mechanisms and the complex network of interactions that govern cell cycle progression.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

Could possibly inhibit CINP by reducing the functional impact of its interaction with CDK2 in cell cycle regulation.

Purvalanol B

212844-54-7sc-361300
sc-361300A
10 mg
50 mg
$199.00
$846.00
(1)

Could possibly inhibit CINP by disrupting its influence on CDK2, affecting cell cycle progression.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$311.00
(2)

As a CDK inhibitor, could possibly inhibit CINP's role in cell cycle regulation.

Indirubin-3′-monoxime

160807-49-8sc-202660
sc-202660A
sc-202660B
1 mg
5 mg
50 mg
$77.00
$315.00
$658.00
1
(1)

Could possibly inhibit CINP by disrupting the interaction between CINP and CDK2, affecting cell cycle control.

Olomoucine

101622-51-9sc-3509
sc-3509A
5 mg
25 mg
$72.00
$274.00
12
(1)

Targeting CDKs, including CDK2, could possibly impact CINP-mediated cell cycle regulation.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

As a selective inhibitor of CDK4/6, could possibly influence CINP's regulatory role through cell cycle modulation.

Dinaciclib

779353-01-4sc-364483
sc-364483A
5 mg
25 mg
$242.00
$871.00
1
(0)

As a potent CDK inhibitor, could possibly affect CINP's interaction with CDK2 and its role in cell cycle progression.

AT-7519 Hydrochloride

902135-91-5sc-482715
5 mg
$125.00
(0)

Inhibiting multiple CDKs, could possibly disrupt CINP's regulatory effects on CDK2.

SU 9516

377090-84-1sc-222330
sc-222330A
5 mg
25 mg
$122.00
$383.00
3
(1)

As a selective CDK2 inhibitor, could possibly modulate CINP's impact on cell cycle regulation.

AZD 5438

602306-29-6sc-361115
sc-361115A
10 mg
50 mg
$205.00
$865.00
(0)

Inhibiting CDK1, 2, and 9, could possibly affect CINP's role in regulating the cell cycle via CDK2 interaction.